Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHA:600329)
China · Delayed Price · Currency is CNY 35.80
+0.26 (0.73%)
Oct 9, 2026, 3:00 PM CST
SHA:600329 Market Cap
SHA:600329 has a market cap or net worth of 23.83 billion as of October 9, 2026. It is the 4,664th most valuable company in the world and the 727th biggest in China. Its market cap has decreased by 17.48% in one year.
Market Cap
23.83B
Enterprise Value
20.39B
Revenue
4.72B
Global Rank
Country Rank
#727 China
PE Ratio
32.40
ChartMarket Cap Chart
Since June 6, 2001, SHA:600329's market cap has increased from 6.92B to 23.83B, an increase of 244.53%. That is a compound annual growth rate of 5.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 23.83B | -22.59% |
| Dec 31, 2025 | 30.78B | 48.69% |
| Dec 31, 2024 | 20.70B | -6.43% |
| Dec 29, 2023 | 22.12B | 21.24% |
| Dec 30, 2022 | 18.25B | -6.30% |
| Dec 31, 2021 | 19.47B | 73.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Dizal (Jiangsu) Pharmaceutical | 27.12B |
| Shijiazhuang Yiling Pharmaceutical | 25.71B |
| Zhejiang Huahai Pharmaceutical | 24.81B |
| Hubei Jumpcan Pharmaceutical | 23.98B |
| Livzon Pharmaceutical Group | 22.85B |
| Walvax Biotechnology | 22.52B |
| Jiangsu Nhwa Pharmaceutical Co., LTD | 22.19B |
| Hybio Pharmaceutical | 20.98B |